Loading...
Bioengineered Platforms for Human Stem Cell-Based Diagnostic and Therapeutic Interventions
Journal Title
Readers/Advisors
Journal Title
Term and Year
Publication Date
2020-08
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Files
Research Projects
Organizational Units
Journal Issue
Abstract
Human stem cells offer an unprecedented ability to restore function lost through disease or
injury by providing options for cell therapies and regenerative medicine. Two hurdles that delay
greater clinical use of stem cells are production of differentiated therapeutic cells in large-scale
platforms and the challenge of choosing the optimum cell type and delivery method for cell therapy
that is optimized for cell-cell signaling in the therapeutic microenvironment. In my thesis work I
investigated different bioengineered platforms in combination with human stem cell technology to
mass produce functional hiPSC-derived beta islets in a miniature bioreactor and study cytokine
release from multipotent and differentiated hiPSC-derived neural stem cells as neural rosettes and
their dissociated cells or differentiating inhibitory and excitatory neurons alone and in mixed
cultures applying a neural cell-cell interaction microchip (NCCIM) with features developed
specifically for these studies. My work has further expanded the application of hiPSC-derived
neurons in an in vitro model of traumatic brain injury. In this study a hybrid culture of hiPSC-derived
excitatory pyramidal neurons, inhibitory GABAergic interneurons and immortalized
human microglia are being evaluated for secreted cytokines under healthy and stretch injured
induced conditions. One of the challenges of TBI is the inability to yet effectively and with
minimal invasiveness track changes following injury that may indicate healing or deterioration
and an in vitro model is one important contribution to identifying biomarkers.